The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Cost-effectiveness of computerized cognitive–behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial
Abstract
Background: Computerized cognitive–behavioural therapy (cCBT) forms a core component of stepped psychological care for depression. Existing evidence for cCBT has been informed by developer-led trials. This is the first study based on a large independent pragmatic trial to assess the cost-effectiveness of cCBT as an adjunct to usual general practitioner (GP) care compared with usual GP care alone and to establish the differential cost-effectiveness of a free-to-use cCBT programme (MoodGYM) in comparison with a commercial programme (Beating the Blues) in primary care. Method: Costs were estimated from a healthcare perspective and outcomes measured using quality-adjusted life years (QALYs) over 2 years. The incremental cost-effectiveness of each cCBT programme was compared with usual GP care. Uncertainty was estimated using probabilistic sensitivity analysis and scenario analyses were performed to assess the robustness of results. Results: Neither cCBT programme was found to be cost-effective compared with usual GP care alone. At a £20 000 per QALY threshold, usual GP care alone had the highest probability of being cost-effective (0.55) followed by MoodGYM (0.42) and Beating the Blues (0.04). Usual GP care alone was also the cost-effective intervention in the majority of scenario analyses. However, the magnitude of the differences in costs and QALYs between all groups appeared minor (and non-significant). Conclusions: Technically supported cCBT programmes do not appear any more cost-effective than usual GP care alone. No cost-effective advantage of the commercially developed cCBT programme was evident compared with the free-to-use cCBT programme. Current UK practice recommendations for cCBT may need to be reconsidered in the light of the results.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The existing digital therapeutic and telehealth interventions with didactic components, which enable health care providers to communicate with patients via digital platforms (eg, email and video call), have encountered several challenges, including relatively low adherence, unsustainability, and inflexibility [3,4].”
From Artificial Intelligence-Based Chatbots for Promoting Health Behavioral Changes: Systematic Review. (2023) · cites this paper as [3]
In the citing paper
“Existing digital therapies have suffered from low adherence and concerns about their efficiency without continued human support [12,13].”
From Conversational agents in the treatment of mental health problems: mixed-method systematic review (2019) · cites this paper as [12]
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · cited 2×
“…with depression according to a self-report questionnaire [score of 5 10 on the Patient Health Questionnaire (PHQ-9) depression severity instrument; Kroenke et al. 2001] who were not in receipt of cCBT or specialist psychological therapy at the time of recruitment were included in the trial.”
BackgroundMethodEuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736 · cited 3×
“…main outcome for the cost-effectiveness analysis was the quality-adjusted life year (QALY) assessed using two standardized generic and preference-based measures: the EQ-5D-3L (Brooks, 1996; The EuroQol Group, 1990) and the SF-6D (derived from the Short-Form-36; SF-36; Brazier et al. 1998, 2002).”
MethodEuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815 · cited 2×
“…main outcome for the cost-effectiveness analysis was the quality-adjusted life year (QALY) assessed using two standardized generic and preference-based measures: the EQ-5D-3L (Brooks, 1996; The EuroQol Group, 1990) and the SF-6D (derived from the Short-Form-36; SF-36; Brazier et al. 1998, 2002).”
MethodDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · cited 1×
“Depression is a highly prevalent condition that makes a considerable impact on patients ’ health-related quality of life (HRQoL) (Moussavi et al. 2007).”
BackgroundDecision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Analysis of serial measurements in medical research.
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,136
The estimation of a preference-based measure of health from the SF-36
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,026 · cited 4×
“…main outcome for the cost-effectiveness analysis was the quality-adjusted life year (QALY) assessed using two standardized generic and preference-based measures: the EQ-5D-3L (Brooks, 1996; The EuroQol Group, 1990) and the SF-6D (derived from the Short-Form-36; SF-36; Brazier et al. 1998, 2002).”
MethodInfluentialMultiple Imputation of Missing Values
Royston, P. (2004) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400301 · Cited by 2,340 · cited 1×
“To account for missing data, we used multiple imputation methods with chained equations (Royston, 2004) and predictive mean matching over 10 imputations to estimate cost aggregated by resource use category (see above) and EQ-5D-3L and SF-6D data items when these were missing.”
MethodGlobal burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · cited 1×
“It is one of the most common reasons for consulting with a general practitioner (GP) and leads to the expenditure of large amounts of healthcare resources (Üstün et al. 2004).”
BackgroundWhat Works for Whom?: A Critical Review of Psychotherapy Research
Roth, A. D., & Fonagy, P. (1996) · Cited by 1,382
Research works printed but not linked: 4
- 2013, Guide to the Methods of Technology Appraisal
- Curtis, 2012, Unit Costs of Health and Social Care 2012
- 2013, British National Formulary
- 2009, Depression: The Treatment and Management of Depression in Adults (Update). Clinical Guideline 90
Cited by
Artificial Intelligence-Based Chatbots for Promoting Health Behavioral Changes: Systematic Review.
Aggarwal, A., Tam, C. C., Wu, D., Li, X., & Qiao, S. (2023) · Journal of medical Internet research · doi:10.2196/40789 · Cited by 683
“…therapeutic and telehealth interventions with didactic components, which enable health care providers to communicate with patients via digital platforms (eg, email and video call), have encountered several challenges, including relatively low adherence, unsustainability, and inflexibility [3,4].”
Conversational agents in the treatment of mental health problems: mixed-method systematic review
Gaffney, H., Mansell, W., & Tai, S. (2019) · JMIR Mental Health · doi:10.2196/14166 · Cited by 275
“Existing digital therapies have suffered from low adherence and concerns about their efficiency without continued human support [12,13].”
Mitchell, L. M., Joshi, U., Patel, V., Lu, C., & Naslund, J. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.092 · Cited by 80
(2019) · Europe PMC (PubMed Central) · Cited by 110
Thase, M. E., McCrone, P., Barrett, M. S., Eells, T. D., Wisniewski, S. R., Balasubramani, G. K., Brown, G. K., & Wright, J. H. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000508143 · Cited by 60
“The importance of therapist support for treatment in clinical populations should not be minimized, however, as one large primary care study [43] that offered only a small amount (less than 10 min on average) of technical support found no clinical advantage compared to usual care.”
Background
Metadata
- Authors
- Duarte, A., Walker, S., Littlewood, E., Brabyn, S., Hewitt, C., Gilbody, S., & Palmer, S.
- Affiliations
- University of York (GB)
- Corresponding author
- Duarte, A.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2017-02-23
- Volume
- 47
- Issue
- 10
- Pages
- 1825-1835
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2590198388
- Cited by
- 30
- References
- 35
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 1 · 2020: 9 · 2019: 3
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- National Institute for Health and Care Research (06/43/504, HTA/06/43/504, 06/43/05)
- National Institutes of Health
- Health Technology Assessment Programme
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- depression, cost-effectiveness, primary care, general practitioner care, MoodGYM, quality-adjusted life years
- MeSH terms
- Adult, Cost-Benefit Analysis, Depression, Depressive Disorder, England, Female, Humans, Male, Middle Aged, Primary Health Care, Therapy, Computer-Assisted, Cognitive Behavioral Therapy, Outcome Assessment, Health Care, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of computerized cognitive–behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. https://app.cochat.ai/papers/10.1017/s0033291717000289
- The paper
- Duarte, A., Walker, S., Littlewood, E., Brabyn, S., Hewitt, C., Gilbody, S., & Palmer, S. (2017). Cost-effectiveness of computerized cognitive–behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Psychological Medicine. https://doi.org/10.1017/s0033291717000289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.